Skip to main content

Clitoral Phimosis and Clitoral Adhesions

Clitoral phimosis is the inability to retract the clitoral prepuce (clitoral hood) to expose the entire glans clitoris. It is a distinct entity from clitoral adhesions, in which the prepuce is directly tethered to the glans by epithelial bridging. Both produce trapped keratin / smegma, periclitoral pseudocyst formation, decreased sensation, dyspareunia, and anorgasmia, and both are most often the architectural sequela of vulvar lichen sclerosus (LS).[1][2][3]

For the underlying dermatologic disease, see Lichen Sclerosus. For aesthetic clitoral-hood reduction in the absence of pathologic phimosis, see Inverted-Y Clitoral Hoodoplasty and Liu Classification Hoodoplasty — those are cosmetic procedures and are not interchangeable with phimosis release.

Definition and Classification​

A 2025 international Delphi consensus (Krapf et al.) standardized terminology:[1]

  • Clitoral phimosis — inability to retract the prepuce to expose the entire glans clitoris.
  • Clitoral adhesions — direct tethering of the prepuce to the glans clitoris.
  • The degree of phimosis should be classified as mild, moderate, or severe, and described as partially retractable or completely non-retractable.
  • Both prepuce characteristics and glans size should be documented.

The two entities frequently coexist (phimotic prepuce with bridging adhesions to the glans beneath) but require different operative approaches — adhesions can often be lysed in the office, whereas phimosis requires surgical preputial release.[1][4]

Prevalence​

PopulationRate
3,650 sexually active women (general cohort)1.3% had any form of clitoral phimosis; severe in 9 cases[5]
Sexual-dysfunction clinic referrals22% — substantially underdiagnosed[2]

Etiology​

CauseNotes
Lichen sclerosus (LS)The dominant etiology — chronic inflammation, epithelial thinning, and progressive scarring fuse the labia minora, phimose the clitoral hood, and create the classic "figure of eight" architectural distortion of the vulva.[3][6]
Lichen planus (LP)Similar scarring mechanism with mucosal involvement[7]
Recurrent vulvar dermal infections / blunt traumaAlters preputial elasticity over time[2]
Congenital fusionRare; can present as a periclitoral mass from trapped sebaceous material[8]
Anatomic predispositionThe glandopreputial sulcus of the clitoris is often incompletely formed (unlike the penile sulcus), predisposing to phimosis, cyst formation, and pilonidal sinus[9]

Clinical Presentation​

  • Sexual dysfunction — decreased clitoral sensation, impaired arousal, anorgasmia, and dyspareunia. Most consistent in severe LS-related phimosis.[5][10]
  • Sexual pain — the symptom most reliably associated with phimosis on regression analysis.[2]
  • Smegma / keratin pearl accumulation beneath the fused prepuce — palpable mass that can mimic vulvar malignancy.[8][11]
  • Pseudocyst formation from trapped eccrine secretions.[9]
  • Pediatric / adolescent LS — phimosis presents alongside labial resorption and adhesion formation; can cause urinary retention or significant pain.[12]

Diagnosis​

  • Exam-based. Cephalad displacement of the labia minora to retract the prepuce. Inability to fully expose the glans confirms the diagnosis.[2]
  • Document phimosis vs adhesion — phimosis is preputial-aperture stenosis; adhesions are epithelial bridges that may be lysed at the bedside.[1]
  • Biopsy to confirm the underlying dermatosis (LS vs LP) is recommended given the 2–5% lifetime risk of vulvar SCC in untreated LS — biopsy any focal hyperkeratosis, fissure, ulcer, or mass.[6]
  • The clitoris should be routinely examined in any patient presenting with sexual dysfunction, vulvar symptoms, or known vulvar dermatoses.[4]

Treatment Ladder​

Treatment is guided by severity, symptom burden, and underlying etiology. Most patients require ongoing dermatologic maintenance even after a successful procedure because the underlying LS / LP is chronic.[7][10]

1. Medical (first-line for the underlying dermatosis)​

  • High-potency topical corticosteroids — clobetasol 0.05% ointment twice daily until active disease regresses (typically 1–2 months), then taper to a maintenance schedule. Prevents progression but does not reverse established architectural changes.[3][6][12]
  • Maintenance therapy is essential to prevent recurrence and reagglutination after any procedure.[7][3]

2. Non-surgical office lysis of adhesions​

For clitoral adhesions specifically (epithelial bridges to the glans), office-based lysis with fine Jacobsen mosquito forceps to separate prepuce from glans, with removal of trapped smegma and keratin pearls. In the Myers 2022 retrospective series:[4]

  • 76% reported pain improvement
  • 63% improved arousal
  • 64% improved orgasmic function
  • 93% would recommend the procedure

This is not appropriate for true preputial-aperture phimosis, which requires surgical release.

3. Surgical management (for moderate–severe phimosis)​

Clitoral circumcision / prepucectomy​

Excision of the phimotic preputial ring to expose the glans clitoris. The Goldstein / Burrows series and Chmel 2019 prospective study:[10][5]

  • FSFI improved from 17.9 → 26.6 at 12 months (p < 0.001)
  • Significant improvement in arousal, orgasm, and dyspareunia domains
  • Concurrent perineoplasty may be required when introital stenosis coexists.[5]

CO₂ laser preputial release​

Used for clitoral phimosis secondary to LS or LP with individualized pre- and postoperative topical therapy. Kroft / Shier series of 23 women:[7]

  • Some reagglutination occurred (5/20 LS patients).
  • 5 patients required reoperation.
  • Overall satisfaction was high.

Surgicel application after lysis​

Oxidized regenerated cellulose (Surgicel) applied to exposed surfaces after surgical lysis of adhesions to prevent reagglutination — Breech 2000 small adolescent series with no recurrence at 1 year.[11]

Postoperative Considerations​

  • Reagglutination is the dominant failure mode — reported in ~25% of LS patients after CO₂ laser.[7]
  • Continued topical-steroid maintenance is critical — the underlying dermatosis drives recurrence.[10][7]
  • Periodic surveillance examination for both reagglutination and for the lifelong vulvar SCC risk in LS patients.[6]

Key Principles​

  • Clitoral phimosis is distinct from clitoral adhesions — the Krapf 2025 Delphi consensus standardized this distinction.[1]
  • LS is the dominant cause; treat the underlying dermatosis with maintenance topical steroids regardless of whether a procedure is offered.[3][6]
  • Adhesions (epithelial bridges) can be lysed in the office; phimosis (preputial-aperture stenosis) requires surgical release.[4][1]
  • Aesthetic clitoral hoodoplasty is not interchangeable with phimosis release — different anatomy, different goals, different outcome instruments.[13]
  • Reagglutination (~25% with CO₂ laser in LS) drives the need for ongoing topical-steroid maintenance.[7]
  • Biopsy suspicious lesions in any LS patient; vulvar SCC risk is 2–5% in untreated LS.[6]
  • Pediatric LS demands early diagnosis — ~50% of children present with already irreversible atrophic changes from diagnostic delay (median 7 months).[12]
  • Clitoral exam is mandatory in any patient with sexual dysfunction, vulvar symptoms, or known vulvar dermatosis — phimosis is markedly underdiagnosed in routine practice (1.3% in general vs 22% in sexual-dysfunction clinics).[5][2]

References​

1. Krapf JM, Pope R, Rubin RS, Moss CF, Mauskar MM. Definition and classification of clitoral phimosis and adhesions: an international Delphi study. BJOG. 2025. doi:10.1111/1471-0528.70066.

2. Munarriz R, Talakoub L, Kuohung W, et al. The prevalence of phimosis of the clitoris in women presenting to the sexual dysfunction clinic: lack of correlation to disorders of desire, arousal and orgasm. J Sex Marital Ther. 2002;28 Suppl 1:181-5. doi:10.1080/00926230252851302.

3. Ringel NE, Iglesia C. Common benign chronic vulvar disorders. Am Fam Physician. 2020;102(9):550-557.

4. Myers MC, Romanello JP, Nico E, et al. A retrospective case series on patient satisfaction and efficacy of non-surgical lysis of clitoral adhesions. J Sex Med. 2022;19(9):1412-1420. doi:10.1016/j.jsxm.2022.06.011.

5. Chmel R, Nováčková M, Fait T, et al. Clitoral phimosis: effects on female sexual function and surgical treatment outcomes. J Sex Med. 2019;16(2):257-266. doi:10.1016/j.jsxm.2018.12.012.

6. Committee on Practice Bulletins–Gynecology. Diagnosis and management of vulvar skin disorders: ACOG Practice Bulletin, Number 224. Obstet Gynecol. 2020;136(1):e1-e14. doi:10.1097/AOG.0000000000003944.

7. Kroft J, Shier M. A novel approach to the surgical management of clitoral phimosis. J Obstet Gynaecol Can. 2012;34(5):465-471. doi:10.1016/S1701-2163(16)35243-4.

8. Maybury EK, Recio FO, Ahmad S, McKenzie ND. Fused clitoral hood presenting as a periclitoral mass. Obstet Gynecol. 2022;140(6):1056-1060. doi:10.1097/AOG.0000000000004996.

9. van der Putte SC, Sie-Go DM. Development and structure of the glandopreputial sulcus of the human clitoris with a special reference to glandopreputial glands. Anat Rec (Hoboken). 2011;294(1):156-64. doi:10.1002/ar.21279.

10. Goldstein AT, Burrows LJ. Surgical treatment of clitoral phimosis caused by lichen sclerosus. Am J Obstet Gynecol. 2007;196(2):126.e1-4. doi:10.1016/j.ajog.2006.08.023.

11. Breech LL, Laufer MR. Surgicel in the management of labial and clitoral hood adhesions in adolescents with lichen sclerosus. J Pediatr Adolesc Gynecol. 2000;13(1):21-2. doi:10.1016/s1083-3188(99)00029-7.

12. Nerantzoulis I, Grigoriadis T, Michala L. Genital lichen sclerosus in childhood and adolescence — a retrospective case series of 15 patients: early diagnosis is crucial to avoid long-term sequelae. Eur J Pediatr. 2017;176(10):1429-1432. doi:10.1007/s00431-017-3004-y.

13. Committee on Adolescent Health Care. Breast and labial surgery in adolescents: ACOG Committee Opinion No. 795. Obstet Gynecol. 2020;135(1):e36-e43. doi:10.1097/AOG.0000000000003621.